SONAR: Study of Diabetic Nephropathy with Atrasentan. A Randomized, Multi-country, Multi-center, Double-blind, Parallel, Placebo-controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy.
Aijaz Gundroo, MD Principal Investigator Rocco C. Venuto, MD Sub-investigator
Andrew H. Talal, MD — who pioneered the use of telemedicine to treat patients with hepatitis C virus (HCV) in opioid treatment programs — has shared the successes of this approach with the National Academy of Medicine (NAM).
Nine faculty members with a variety of clinical and research experience — representing five medical school departments — have joined the Jacobs School of Medicine and Biomedical Sciences over the past several months.
Alzheimer's Disease and other dementias affect over 50 million people worldwide. Early intervention is crucial. The sooner it's diagnosed, the better the disease's progression can be slowed, allowing for more time with an increased quality of life.